OneSource Specialty Pharma Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 2,289

Employees

  • Stock Symbol
  • 544292

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $17.16
  • (As of Friday Closing)

OneSource Specialty Pharma General Information

Description

OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company's reportable segment is CDMO (Contract Development and ManufacturingOrganization (CDMO) : Development and manufacture of pharmaceutical products and associated services).

Contact Information

Formerly Known As
Stelis Biopharma, Agila Biotech, Inbiopro Solutions
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Star 1, Opposite IIM Bangalore
  • Bilekahalli, Bannerghatta Road
  • Bengaluru, Karnataka 560076
  • India
+91 080678
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • Star 1, Opposite IIM Bangalore
  • Bilekahalli, Bannerghatta Road
  • Bengaluru, Karnataka 560076
  • India
+91 080678

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OneSource Specialty Pharma Stock Performance

As of 13-Nov-2026, OneSource Specialty Pharma’s stock price is $17.16. Its current market cap is $1.97B with 115M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.16 $17.26 $11.71 - $21.09 $1.97B 115M 47.8K

OneSource Specialty Pharma Financials Summary

As of 30-Sep-2026, OneSource Specialty Pharma has a trailing 12-month revenue of $182M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 1,972,837 1,898,180 2,398,367
Revenue 181,605 160,879 170,873 20,767
EBITDA 42,519 32,401 40,818 (24,874)
Net Income (175) (8,352) (2,125) (47,250)
Total Assets 893,907 870,142 882,664 156,920
Total Debt 182,699 159,396 110,176 68,491
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OneSource Specialty Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OneSource Specialty Pharma‘s full profile, request access.

Request a free trial

OneSource Specialty Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore OneSource Specialty Pharma‘s full profile, request access.

Request a free trial

OneSource Specialty Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture and commercialization of biological
Drug Discovery
Bengaluru, India
2,289 As of 2026

Mumbai, India

Bangalore, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OneSource Specialty Pharma Competitors (5)

One of OneSource Specialty Pharma’s 5 competitors is BDR Pharmaceuticals Internationals, a Private Equity-Backed company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BDR Pharmaceuticals Internationals Private Equity-Backed Mumbai, India
Kemwell Biopharma Corporation Bangalore, India
Farbe Firma Pvt. Corporation Ankleshwar, India
Axxelent Pharma Science Pvt Corporation Chennai, India
Sovereign Pharmaceuticals Corporate Backed or Acquired Fort Worth, TX
You’re viewing 5 of 5 competitors. Get the full list »

OneSource Specialty Pharma Patents

OneSource Specialty Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180037604-A1 Process for the purification of recombinant proteins Inactive 04-Aug-2016
US-20140221606-A1 Aspart proinsulin compositions and methods of producing aspart insulin analogs Inactive 23-Feb-2011
US-20160024168-A1 Aspart proinsulin compositions and methods of producing aspart insulin analogs Inactive 23-Feb-2011
US-20120214963-A1 Aspart proinsulin compositions and methods of producing aspart insulin analogs therefrom Inactive 23-Feb-2011
US-20120214965-A1 Glargine proinsulin and methods of producing glargine insulin analogs therefrom Inactive 23-Feb-2011 C07K14/62
To view OneSource Specialty Pharma’s complete patent history, request access »

OneSource Specialty Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OneSource Specialty Pharma Investments & Acquisitions (2)

OneSource Specialty Pharma’s most recent deal was a Merger/Acquisition with Brooks Steriscience. The deal was made on 12-Nov-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Brooks Steriscience 12-Nov-2025 Merger/Acquisition Drug Discovery
Bioprocess Scale-up Lab (Merck/Stelis Biopharma) 12-May-2017 Joint Venture Other Commercial Services
To view OneSource Specialty Pharma’s complete investments and acquisitions history, request access »

OneSource Specialty Pharma ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

39.48 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view OneSource Specialty Pharma’s complete esg history, request access »

OneSource Specialty Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Stelis Biopharma (Manufacturing Unit In Bengaluru, India) Bommasandra, India

OneSource Specialty Pharma FAQs

  • When was OneSource Specialty Pharma founded?

    OneSource Specialty Pharma was founded in 2007.

  • Where is OneSource Specialty Pharma headquartered?

    OneSource Specialty Pharma is headquartered in Bengaluru, India.

  • What is the size of OneSource Specialty Pharma?

    OneSource Specialty Pharma has 2,289 total employees.

  • What industry is OneSource Specialty Pharma in?

    OneSource Specialty Pharma’s primary industry is Drug Discovery.

  • Is OneSource Specialty Pharma a private or public company?

    OneSource Specialty Pharma is a Public company.

  • What is OneSource Specialty Pharma’s stock symbol?

    The ticker symbol for OneSource Specialty Pharma is 544292.

  • What is the current stock price of OneSource Specialty Pharma?

    As of 13-Nov-2026 the stock price of OneSource Specialty Pharma is $17.16.

  • What is the current market cap of OneSource Specialty Pharma?

    The current market capitalization of OneSource Specialty Pharma is $1.97B.

  • What is OneSource Specialty Pharma’s current revenue?

    The trailing twelve month revenue for OneSource Specialty Pharma is $182M.

  • Who are OneSource Specialty Pharma’s competitors?

    BDR Pharmaceuticals Internationals, Kemwell Biopharma, Farbe Firma Pvt., Axxelent Pharma Science Pvt, and Sovereign Pharmaceuticals are competitors of OneSource Specialty Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process